Coagulation Test Changes Associated with Acute Normovolemic Hemodilution in Cardiac Surgery

Overview

About this study

The specific aim of this study is to determine best practice in management of cardiac surgical patients with post- cardiopulmonary bypass (CBP)coagulopathy and bleeding. The aim is to compare outcomes in patients who receive acute normovolemic hemodilution (ANH) blood to control patients with post-CPB factor mediated coagulopathy and clinically significant microvascular bleeding who have did not receive ANH.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

18 years of age or older
Undergoing a cardiac surgical procedure utilizing cardiopulmonary bypass
Permission to use medical records in research

Exclusion Criteria:

Unable to grant informed consent or comply with study procedure
Patient refusal of FWB withdrawal.
Undergoing emergency open heart-surgery
Less than 18 years of age
Pregnant

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Mark Smith, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Mark Smith, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials